UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:PRKCQ_TNS1 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: PRKCQ_TNS1 | KinaseFusionDB ID: KFG4980 | FusionGDB2.0 ID: KFG4980 | Hgene | Tgene | Gene symbol | PRKCQ | TNS1 | Gene ID | 5588 | 7145 | |
Gene name | protein kinase C theta | tensin 1 | ||||||||||
Synonyms | PRKCT|nPKC-theta | MST091|MST122|MST127|MSTP091|MSTP122|MSTP127|MXRA6|PPP1R155|TNS | ||||||||||
Cytomap | 10p15.1 | 2q35 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | protein kinase C theta type | tensin-1Matrix-remodelling-associated protein 6matrix-remodelling associated 6protein phosphatase 1, regulatory subunit 155 | ||||||||||
Modification date | 20240305 | 20240407 | ||||||||||
UniProtAcc | Q04759 | Q9HBL0 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000263125, ENST00000397176, ENST00000539722, | ENST00000171887, ENST00000310858, ENST00000419504, ENST00000430930, ENST00000480665, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: PRKCQ [Title/Abstract] AND TNS1 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | PRKCQ(6530373)-TNS1(218858491), # samples:1 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PRKCQ | GO:0006468 | protein phosphorylation | 34593629 |
Hgene | PRKCQ | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 16356855 |
Kinase Fusion gene breakpoints across PRKCQ (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across TNS1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChiTaRS5.0 | DL057791 | PRKCQ | chr10 | 6530373 | TNS1 | chr2 | 218858491 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:6530373/:218858491) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
PRKCQ | TNS1 |
FUNCTION: Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity (PubMed:23509302). {ECO:0000269|PubMed:11342610, ECO:0000269|PubMed:14988727, ECO:0000269|PubMed:15364919, ECO:0000269|PubMed:16252004, ECO:0000269|PubMed:16356855, ECO:0000269|PubMed:16709830, ECO:0000269|PubMed:19549985, ECO:0000269|PubMed:23509302, ECO:0000269|PubMed:8657160}. | FUNCTION: May act as a protein phosphatase and/or a lipid phosphatase (Probable). Involved in fibrillar adhesion formation (PubMed:21768292, PubMed:28005397). Essential for myofibroblast differentiation and myofibroblast-mediated extracellular matrix deposition (PubMed:28005397). Enhances RHOA activation in the presence of DLC1 (PubMed:26427649). Plays a role in cell polarization and migration (PubMed:19826001). May be involved in cartilage development and in linking signal transduction pathways to the cytoskeleton (PubMed:21768292). {ECO:0000269|PubMed:19826001, ECO:0000269|PubMed:21768292, ECO:0000269|PubMed:26427649, ECO:0000269|PubMed:28005397, ECO:0000305}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of PRKCQ_TNS1 |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
PRKCQ | Q04759 | human | HEXIM1 | O94992 | S158 | KKHRRRPsKKKRHWk | |
PRKCQ | Q04759 | human | RDX | P35241 | T564 | AGRDKyKtLRQIRQG | ERM_C |
PRKCQ | Q04759 | human | LLGL1 | Q15334 | S663 | LkKsLRQsFRRIRKs | |
PRKCQ | Q04759 | human | PDPK1 | O15530 | S241 | skQARANsFVGtAQy | Pkinase |
PRKCQ | Q04759 | human | CARD11 | Q9BXL7 | S893 | sPRLSRAsFLFGQLL | |
PRKCQ | Q04759 | human | BAD | Q92934 | S75 | EIRsRHssyPAGtED | Bcl-2_BAD |
PRKCQ | Q04759 | human | LLGL1 | Q15334 | S673 | RIRKsRVsGKKRAAN | |
PRKCQ | Q04759 | human | NKD2 | Q969F2 | S31 | FVASAYAsGRKGAEE | |
PRKCQ | Q04759 | human | EZR | P15311 | T567 | QGRDkyKtLRQIRQG | ERM_C |
PRKCQ | Q04759 | human | PDPK1 | O15530 | S64 | EPRPGAGsLQHAQPP | |
PRKCQ | Q04759 | human | PRKCQ | Q04759 | T219 | SAINSREtMFHkERF | |
PRKCQ | Q04759 | human | IRS1 | P35568 | S1101 | GCRRRHssEtFsStP | |
PRKCQ | Q04759 | human | RANGAP1 | P46060 | S504 | LMQKAFNsssFNSNT | RanGAP1_C |
PRKCQ | Q04759 | human | PTPN7 | P35236 | S246 | QYQEERRsVkHILFS | Y_phosphatase |
PRKCQ | Q04759 | human | CCDC88A | Q3V6T2 | S1690 | LQQFLEEsNKLTSVQ | |
PRKCQ | Q04759 | human | HPCAL1 | P37235 | T149 | EStPEKRtDKIFRQM | EF-hand_7 |
PRKCQ | Q04759 | human | RASGRP1 | O95267 | T184 | RDWSRKLtQRIKSNT | |
PRKCQ | Q04759 | human | CARD11 | Q9BXL7 | S559 | QPPRsRssIMsITAE | |
PRKCQ | Q04759 | human | NR2F6 | P10588 | S83 | CKSFFKRsIRRNLsY | zf-C4 |
PRKCQ | Q04759 | human | LLGL1 | Q15334 | S655 | GPLSRVKsLkKsLRQ | |
PRKCQ | Q04759 | human | H3C1 | P68431 | S10 | tkQtArkstGGkAPr | Histone |
PRKCQ | Q04759 | human | LLGL1 | Q15334 | S659 | RVKsLkKsLRQsFRR | |
PRKCQ | Q04759 | human | KRAS | P01116-2 | S181 | GKKKKkKskTkCVIM | |
PRKCQ | Q04759 | human | PTPN6 | P29350 | S591 | DKEKsKGsLKRK___ | |
PRKCQ | Q04759 | human | LLGL1 | Q15334 | S670 | sFRRIRKsRVsGKKR | |
PRKCQ | Q04759 | human | FOSL1 | P15407 | S265 | PSSDPLGsPtLLAL_ | |
PRKCQ | Q04759 | human | MSN | P26038 | T558 | LGRDKyKtLRQIRQG | ERM_C |
PRKCQ | Q04759 | human | WIPF1 | O43516 | S488 | RNESRSGsNRRErGA | |
PRKCQ | Q04759 | human | RAPGEF2 | Q9Y4G8 | S960 | KKRVRRssFLNAKKL | |
PRKCQ | Q04759 | human | CBLB | Q13191 | S282 | KysTKPGsYIFRLSC | Cbl_N3 |
PRKCQ | Q04759 | human | HABP4 | Q5JVS0 | T375 | GRGARGGtRGGRGRI | IHABP4_N |
PRKCQ | Q04759 | human | STK39 | Q9UEW8 | S323 | LCLQkDPskRPTAAE | Pkinase |
PRKCQ | Q04759 | human | PTPN7 | P35236 | S44 | RLQERrGsNVALMLD | |
PRKCQ | Q04759 | human | ICAM3 | P32942 | S518 | REHQRsGsyHVREEs | |
PRKCQ | Q04759 | human | FOSL1 | P15407 | T230 | tPSLtPFtPSLVFTY | |
PRKCQ | Q04759 | human | FOSL1 | P15407 | T223 | HtPTLMTtPSLtPFt | |
PRKCQ | Q04759 | human | HABP4 | Q5JVS0 | T354 | RKPANDItSQLEINF | IHABP4_N |
PRKCQ | Q04759 | human | BAD | Q92934 | S99 | PFrGrsRsAPPNLWA | Bcl-2_BAD |
PRKCQ | Q04759 | human | PPP1R12A | O14974 | T853 | PREKRRstGVsFWtQ | |
PRKCQ | Q04759 | human | RANGAP1 | P46060 | S506 | QKAFNsssFNSNTFL | RanGAP1_C |
PRKCQ | Q04759 | human | ARHGEF6 | Q15052 | S225 | KSSERPLsPkAVkGF | |
PRKCQ | Q04759 | human | TBK1 | Q9UHD2 | S716 | HILERFGsLTMDGGL | |
PRKCQ | Q04759 | human | ARHGEF6 | Q15052 | S488 | LSASPRMsGFIyQGk | PH |
PRKCQ | Q04759 | human | STK39 | Q9UEW8 | S309 | MMKKyGKsFRkLLSL | Pkinase |
PRKCQ | Q04759 | human | RASGRP3 | Q8IV61 | T133 | YDWMRRVtQRKKVSK |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
PRKCQ | ID | Description | 0.00e+00 |
PRKCQ | GO:0007159 | leukocyte cell-cell adhesion | 1.47e-05 |
PRKCQ | GO:0032943 | mononuclear cell proliferation | 1.12e-04 |
PRKCQ | GO:0022407 | regulation of cell-cell adhesion | 1.12e-04 |
PRKCQ | GO:0050856 | regulation of T cell receptor signaling pathway | 1.12e-04 |
PRKCQ | GO:1902946 | protein localization to early endosome | 1.12e-04 |
PRKCQ | GO:1905668 | positive regulation of protein localization to endosome | 1.12e-04 |
PRKCQ | GO:0002764 | immune response-regulating signaling pathway | 1.12e-04 |
PRKCQ | GO:0042098 | T cell proliferation | 1.12e-04 |
PRKCQ | GO:0002064 | epithelial cell development | 1.12e-04 |
PRKCQ | GO:0070661 | leukocyte proliferation | 1.12e-04 |
PRKCQ | GO:1905666 | regulation of protein localization to endosome | 1.12e-04 |
PRKCQ | GO:0061028 | establishment of endothelial barrier | 1.12e-04 |
PRKCQ | GO:1903651 | positive regulation of cytoplasmic transport | 1.54e-04 |
PRKCQ | GO:0050863 | regulation of T cell activation | 1.54e-04 |
PRKCQ | GO:1903037 | regulation of leukocyte cell-cell adhesion | 1.54e-04 |
PRKCQ | GO:0050870 | positive regulation of T cell activation | 1.91e-04 |
PRKCQ | GO:0051347 | positive regulation of transferase activity | 2.21e-04 |
PRKCQ | GO:0001885 | endothelial cell development | 2.21e-04 |
PRKCQ | GO:2000641 | regulation of early endosome to late endosome transport | 2.25e-04 |
PRKCQ | GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 2.25e-04 |
PRKCQ | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 2.46e-04 |
PRKCQ | GO:0072659 | protein localization to plasma membrane | 2.93e-04 |
PRKCQ | GO:0035739 | CD4-positiv | 5.47e-06 |
PRKCQ | GO:0046651 | lymphocyte proliferation | 3.65e-04 |
PRKCQ | GO:1903829 | positive regulation of protein localization | 3.65e-04 |
PRKCQ | GO:0050860 | negative regulation of T cell receptor signaling pathway | 3.74e-04 |
PRKCQ | GO:0022409 | positive regulation of cell-cell adhesion | 4.40e-04 |
PRKCQ | GO:0036010 | protein localization to endosome | 4.43e-04 |
PRKCQ | GO:0051251 | positive regulation of lymphocyte activation | 4.73e-04 |
PRKCQ | GO:0033674 | positive regulation of kinase activity | 5.16e-04 |
PRKCQ | GO:1990778 | protein localization to cell periphery | 6.51e-04 |
PRKCQ | GO:1903649 | regulation of cytoplasmic transport | 6.60e-04 |
PRKCQ | GO:0045732 | positive regulation of protein catabolic process | 6.66e-04 |
PRKCQ | GO:0045577 | regulation of B cell differentiation | 6.66e-04 |
PRKCQ | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 6.66e-04 |
PRKCQ | GO:0002696 | positive regulation of leukocyte activation | 8.56e-04 |
PRKCQ | GO:0050867 | positive regulation of cell activation | 1.05e-03 |
PRKCQ | GO:0045446 | endothelial cell differentiation | 1.37e-03 |
PRKCQ | GO:0045022 | early endosome to late endosome transport | 1.41e-03 |
PRKCQ | GO:0046640 | regulation of alpha-beta T cell proliferation | 1.41e-03 |
PRKCQ | GO:0045088 | regulation of innate immune response | 1.42e-03 |
PRKCQ | GO:0046633 | alpha-beta T cell proliferation | 1.64e-03 |
PRKCQ | GO:0031295 | T cell costimulation | 1.71e-03 |
PRKCQ | GO:0098927 | vesicle-mediated transport between endosomal compartments | 1.78e-03 |
PRKCQ | GO:0031294 | lymphocyte costimulation | 1.85e-03 |
PRKCQ | GO:0003158 | endothelium development | 1.99e-03 |
PRKCQ | GO:0050852 | T cell receptor signaling pathway | 2.01e-03 |
PRKCQ | GO:0045785 | positive regulation of cell adhesion | 2.40e-03 |
PRKCQ | GO:0002279 | mast cell activation involved in immune response | 2.40e-03 |
Top |
Related Drugs to PRKCQ_TNS1 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning PRKCQ-TNS1 and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to PRKCQ_TNS1 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |